INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
90 hedge funds and large institutions have $240M invested in Inozyme Pharma in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
37% less capital invested
Capital invested by funds: $382M → $240M (-$142M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
90
Holding in Top 10
1
Calls
$80K
Puts
$19K
Top Buyers
| 1 | +$5.09M | |
| 2 | +$4.84M | |
| 3 | +$3.37M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.27M |
| 5 |
SC
Samlyn Capital
New York
|
+$1.95M |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$2.09M | |
| 3 | -$1.71M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.23M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$864K |